alexa Effects Of Exogenous Luteinizing Hormone On Patients With Relative LH Defi Ciency After Pituitary Down-regulation During Controlled Ovarian Hyperstimulation | 7184
ISSN: 2161-0665

Pediatrics & Therapeutics
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Effects of exogenous luteinizing hormone on patients with relative LH defi ciency after pituitary down-regulation during controlled ovarian hyperstimulation

International Conference on Pediatrics & Gynecology

Zhihong Niu, Yun Feng, Aijun Zhang, Yijuan Sun and Xiaowei Lu

Accepted Abstracts-2011: Pediatr Therapeut

DOI: 10.4172/2161-0665.S1.06

Background: Th e eff ect of exogenous LH supplementation on ovarian stimulation parameters, as well as treatment outcome was evaluated in patients with relative LH defi ciency (serum FSH/LH ration≥3 on stimulation day 1 aft er pituitary down- regulation with a GnRH agonist) and ovarian stimulation with recombinant FSH (rFSH) during IVF/ICSI cycles. Methods: Th e patients with serum FSH/LH ration≥3 on stimulation day 1 aft er pituitary down-regulation with a GnRH agonist were randomly divided into two groups: group 1, using f-FSH alone and no hMG addition through the stimulation procedures (n=143) and group 2, receiving human menopause gonadotropin (hMG) supplementation from the 7 th day of stimulation (n=142). Treatment outcomes and relative hormone levels in both groups were compared. Results: Th ere ware no statistic diff erence on serum FSH, LH, E2 and progesterone level between two groups on baseline, stimulation day 1 and day 7. Patients in group 2, despite with fewer days of stimulation (9.6?0.8 vs. 9.9?1.1 P =0.009) and administering fewer amounts of total gonadotropin than group1 (30.6 ? 4.5 vs. 33 ? 4.1, P  0.001), have higher serum E2 concentration on HCG day compared to group 1( 2615?1196 versus 2248?1028pg/ml, P =0.006). Th e two groups gained almost the similar number of oocytes but group 2 gained higher number of viable embryos (4.3?1.4 versus 3.8?1.5, P=0.004). Further, compared to group1, group 2 had higher proportion of patients with serum E2 reaching 3000-4000pg/ml (30.8% versus 18.5%, P<0.05) and higher number of follicle with average diameter in range of 10-14 mm on hCG day (7.5?1.8 versus 6.3?2.0, P<0.05). No signifi cant diff erences ware found for other variables such as number of embryo transferred and pregnancy outcomes. Conclusions: In stimulation protocol with pituitary down-regulation by a GnRH agnist, exogenous LH addition by hMG from stimulation day 7 could increase ovarian response and improve embryo quality for patients with FSH/LH ≥3 on the fi rst day of ovarian stimulation.
Leave Your Message 24x7